4//SEC Filing
ISALY SAMUEL D 4
Accession 0000947871-18-000012
CIK 0001583648other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:23 PM ET
Size
11.4 KB
Accession
0000947871-18-000012
Insider Transaction Report
Form 4
ORBIMED ADVISORS LLC
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-03$7.35/sh−1,693,492$12,447,166→ 5,500,730 total(indirect: See Footnotes) - Sale
Common Stock
2018-01-03$7.35/sh−16,128$118,541→ 49,270 total(indirect: See Footnotes)
OrbiMed Capital GP III LLC
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-03$7.35/sh−1,693,492$12,447,166→ 5,500,730 total(indirect: See Footnotes) - Sale
Common Stock
2018-01-03$7.35/sh−16,128$118,541→ 49,270 total(indirect: See Footnotes)
ISALY SAMUEL D
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-03$7.35/sh−1,693,492$12,447,166→ 5,500,730 total(indirect: See Footnotes) - Sale
Common Stock
2018-01-03$7.35/sh−16,128$118,541→ 49,270 total(indirect: See Footnotes)
Footnotes (4)
- [F1]These shares of the Issuer's common stock ("Shares") were sold in a block order at a price of $7.35.
- [F2]These Shares are held of record by OrbiMed Private Investments III, LP ("OPI III"). OrbiMed Capital GP III LLC ("GP III") is the general partner of OPI III, and OrbiMed Advisors LLC ("Advisors") is the managing member of GP III. Samuel D. Isaly ("Isaly"), a natural person, is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, GP III, Advisors and Isaly may be deemed to have voting and investment power over the securities held by OPI III and as a result may be deemed to have beneficial ownership over such securities.
- [F3]These Shares are held of record by OrbiMed Associates III, LP ("Associates III"). Advisors is the general partner of Associates III. Isaly is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, Advisors and Isaly may be deemed to have voting and investment power over the securities held by Associates III and as a result may be deemed to have beneficial ownership over such securities.
- [F4]This report on Form 4 is jointly filed by GP III, Advisors, and Isaly. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
Related Parties
1- filerCIK 0001055949
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 3:23 PM ET
- Size
- 11.4 KB